AstraZeneca Approves Covid-19 Vaccine Produced by “Siam Bioscience” for Distribution

AstraZeneca announces that the COVID-19 vaccine produced by Siam Bioscience has been approved for distribution within this week after a certification for quality and safety standards from local regulators.

Moreover, the vaccine produced by Siam Bioscience also passed the quality examination criteria from AstraZeneca’s analytical laboratories overseas. This confirms the quality of the COVID-19 vaccine made in Thailand that meets international standards.

Vaccine rollout in Thailand is expected to be on June 7, 2021.